Orchard Therapeutics plc ORTX
$ 4.93
1.02%
Quarterly report 2023-Q3
added 11-13-2023
Country |
Britain |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Prof. Bobby Gaspar Ph.D., M.D. |
Employees in the company |
252 |
Shares |
128 M |
Market Cap[1] |
$ 90.8 M |
EBITDA (LTM) |
$ -94.9 M |
P/E (LTM) |
-6.94 |
P/S (LTM) |
4.4 |
EPS (LTM) |
-0.71 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.